RXi Pharmaceuticals to Host Year-End 2009 Earnings Conference Call and Webcast on Wednesday, March 31, 2010

WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that its financial results for the year ending 2009 will be released on Wednesday, March 31, 2010.
MORE ON THIS TOPIC